PD
LXRX icon

Point72 (DIFC)’s Lexicon Pharmaceuticals LXRX Stock Holding History

Point72 (DIFC)’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$20 Sell
15
-6,967
-100% -$7.91K ﹤0.01% 1116
2025
Q2 		$6.6K Sell
6,982
-6,345
-48% -$4.11K ﹤0.01% 1355
2025
Q1 		$6.14K Buy
+13,327
New +$8.41K ﹤0.01% 1509

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 (DIFC)'s LXRX Position: Q3 2025 in Review

Point72 (DIFC) reduced its Lexicon Pharmaceuticals (LXRX) stake by 100% in Q3 2025, selling an estimated $7.91K and leaving 15 shares worth $20. The position accounts for ﹤0.01% of the portfolio, ranked #1116.

Point72 (DIFC) first reported a position in LXRX in Q1 2025 and has held it in 3 quarters since. The position peaked at $6.6K in Q2 2025. 123 funds tracked by Wall St. Rank hold LXRX as of Q3 2025.

  • Point72 (DIFC) held 15 shares of Lexicon Pharmaceuticals worth $20 as of Q3 2025.
  • Point72 (DIFC) sold 6,967 Lexicon Pharmaceuticals shares in Q3 2025, an estimated $7.91K.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #1116 holding.
  • Point72 (DIFC) first reported a position in Lexicon Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • Point72 (DIFC)'s Lexicon Pharmaceuticals position peaked at $6.6K in Q2 2025.
  • 123 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.